Lv4
730 积分 2023-06-12 加入
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
12小时前
待确认
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer
3个月前
已完结
The adenosine pathway in immuno-oncology
4个月前
已完结
MTHFD2: A significant mitochondrial metabolic enzyme and a novel target for anticancer therapy
4个月前
已完结
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?
4个月前
已关闭
TIGIT’s immuno-oncology teachings
4个月前
已完结
OA08.01 BMS-986504 in Patients With Homozygous MTAP-Deletion (Del): Clinical Results in Patients With NSCLC Enrolled in CA240-0007
5个月前
已关闭
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
5个月前
已完结
皖公网安备34019202002308
